EcoDrugPlus

Exportin 1

Ensembl ID : ENSDORG00000013050
Gene Symbol: XPO1
3 Cross references
296 Possible Orthologues:

Farnesyl Diphosphate Synthase

Ensembl ID : ENSDORG00000005366
Gene Symbol: FDPS
4 Cross references
268 Possible Orthologues:

Farnesyl-Diphosphate Farnesyltransferase 1

Ensembl ID : ENSDORG00000012478
Gene Symbol: FDFT1
4 Cross references
218 Possible Orthologues:

Farnesyltransferase, Caax Box, Alpha

Ensembl ID : ENSDORG00000016106
Gene Symbol: FNTA
3 Cross references
220 Possible Orthologues:

Fatty Acid Amide Hydrolase

Ensembl ID : ENSDORG00000015089
Gene Symbol: FAAH
3 Cross references
131 Possible Orthologues:

Fibroblast Activation Protein Alpha

Ensembl ID : ENSDORG00000001902
Gene Symbol: FAP
3 Cross references
127 Possible Orthologues:

Fibroblast Growth Factor 2

Ensembl ID : ENSDORG00000027523
Gene Symbol: FGF2
4 Cross references
117 Possible Orthologues:

Fibroblast Growth Factor Receptor 1

Ensembl ID : ENSDORG00000002210
Gene Symbol: FGFR1
4 Cross references
293 Possible Orthologues:

Fibroblast Growth Factor Receptor 2

Ensembl ID : ENSDORG00000005639
Gene Symbol: FGFR2
3 Cross references
218 Possible Orthologues:

Fibroblast Growth Factor Receptor 3

Ensembl ID : ENSDORG00000009704
Gene Symbol: FGFR3
2 Cross references
195 Possible Orthologues:

Fibroblast Growth Factor Receptor 4

Ensembl ID : ENSDORG00000013756
Gene Symbol: FGFR4
3 Cross references
123 Possible Orthologues:

Fms Related Receptor Tyrosine Kinase 1

Ensembl ID : ENSDORG00000014729
Gene Symbol: FLT1
4 Cross references
199 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).